Consolidated Planning Corp Has $477,000 Stock Holdings in Cabot Co. (NYSE:CBT)

Consolidated Planning Corp increased its holdings in shares of Cabot Co. (NYSE:CBT) by 27.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 5,227 shares of the specialty chemicals company’s stock after purchasing an additional 1,130 shares during the period. Consolidated Planning Corp’s holdings in Cabot were worth $477,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Geode Capital Management LLC increased its stake in Cabot by 1.8% during the third quarter. Geode Capital Management LLC now owns 1,283,686 shares of the specialty chemicals company’s stock valued at $143,504,000 after acquiring an additional 22,719 shares during the period. Copeland Capital Management LLC increased its stake in Cabot by 21.6% during the fourth quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company’s stock valued at $69,521,000 after acquiring an additional 135,119 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Cabot by 2.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 707,433 shares of the specialty chemicals company’s stock valued at $79,070,000 after acquiring an additional 19,215 shares during the period. JPMorgan Chase & Co. increased its stake in Cabot by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 355,334 shares of the specialty chemicals company’s stock valued at $39,716,000 after acquiring an additional 41,554 shares during the period. Finally, Eastern Bank increased its stake in Cabot by 577.1% during the third quarter. Eastern Bank now owns 269,270 shares of the specialty chemicals company’s stock valued at $30,096,000 after acquiring an additional 229,500 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Stock Down 0.6 %

NYSE CBT opened at $85.51 on Thursday. The firm has a market cap of $4.64 billion, a PE ratio of 11.36, a price-to-earnings-growth ratio of 0.76 and a beta of 1.19. Cabot Co. has a one year low of $78.61 and a one year high of $117.46. The stock’s 50 day simple moving average is $92.03 and its 200 day simple moving average is $101.51. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.36.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, sell-side analysts forecast that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot declared that its board has initiated a stock repurchase program on Tuesday, December 3rd that permits the company to buyback 10,000,000 outstanding shares. This buyback authorization permits the specialty chemicals company to buy shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s board believes its shares are undervalued.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend is Friday, February 28th. Cabot’s dividend payout ratio is 22.84%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. StockNews.com lowered Cabot from a “buy” rating to a “hold” rating in a research note on Monday. JPMorgan Chase & Co. lowered Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 price objective on the stock. in a research note on Monday, November 11th. Finally, Mizuho lowered their price objective on Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $102.00.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.